Phytocannabinoids in Triple Negative Breast Cancer Treatment: Current Knowledge and Future Insights

Pre-clinical studies highlighted various antitumor activities of plant-derived Cannabis sativa and synthetic cannabinoids (CBs). However, some studies indicated that CBs might also promote tumor progression. The authors review known and possible interactions between cannabinoids and TNBC therapies.